Our findings showed that the primary anti-tumor activity from the DSF-CuCl2 complex included cell cycle, cell proliferation, senescence, ROS, mitochondrial dysfunctions, ROS-induced HIF-1α, and c-Myc expression. The gene discussed is HIF1A; the disease is neoplasm.